Note: AEye, Inc. (ticker LIDR) should not be confused with the unrelated Nasdaq-listed "AudioEye, Inc." (ticker AEYE), a digital-accessibility software company that frequently surfaces in ticker/name searches. Every figure below pertains strictly to AEye, Inc., the LiDAR sensor company.
AEye's core product is Apollo (built on its "4Sight" platform), a software-defined, adaptive solid-state LiDAR operating at 1550nm with a claimed behind-the-windshield form factor — a genuine, industry-desired technical characteristic per independent commentary. Rather than concentrate on automotive alone, AEye markets deliberately across defense, sports analytics, smart infrastructure, rail and trucking. Its commercial narrative rests on a growing but still tiny base of 25 revenue-generating customers as of Q2 2026 (up from 16 a year earlier), a lead defense customer's third consecutive purchase order, and membership in the NVIDIA Halos AI Systems Inspection Lab (announced March 16, 2026) — news that alone drove an approximately +52.3% single-day stock rally, a real, sourced illustration of how sharply speculative and news-driven this stock is. No confirmed, named automotive OEM series-production design win was identified anywhere in the sourced research.
Financially, AEye is effectively pre-revenue: Q2 2026 revenue was just $202K (up from $22K a year earlier) but carried a negative gross margin (-$161K gross loss), and GAAP net loss was $10.0M for the quarter. Cash and marketable securities stood at $71.503M as of June 30, 2026 against 45,915,091 weighted-average diluted shares — current cash/share of approximately $1.56, notably above the current $1.220 share price, meaning AEye trades below its own disclosed cash balance per share. Because a standard revenue or earnings multiple is not meaningful on this tiny, negative-margin revenue base, our valuation framework here is cash-adequacy, not a growth multiple.
Net: SELL. Framing valuation around the forward (12-month-out) cash trajectory — company-guided FY2026 cash burn of $30-35M (midpoint $32.5M) against the current $71.503M cash balance — projects cash in 12 months of approximately $39.0M, or forward cash/share of approximately $0.85, which is where this report anchors its target. We weight heavily against this: an active $200M Form S-3 shelf and ongoing ATM sales no longer capped by "baby shelf" resale rules since July 2025, a structural, near-certain dilution risk; a twice-breached Nasdaq $1.00 minimum-bid-price rule (cured via a 1-for-30 reverse split in December 2023, and again via price recovery in July 2025) with the stock's 52-week low of $1.01 leaving it structurally close to a third breach; and, importantly, whether a "substantial doubt" going-concern qualification from a 2025-era filing has been formally lifted in the current (Q2 2026) financials could not be confirmed from primary source text in the underlying research — an open item the reader should independently check, not a resolved fact in either direction.
AEye is a Delaware-domiciled US issuer that went public via SPAC merger with CF Finance Acquisition Corp. III (a Cantor Fitzgerald-sponsored SPAC, merger closed 2021), and files under the standard SEC domestic-issuer regime (Form 10-K, 10-Q, 8-K). Nasdaq Listing Rule 5550(a)(2), the $1.00 minimum-bid-price requirement, is directly and repeatedly relevant to AEye's compliance history.
The capital-light operating model has kept cash burn within guided ranges ($29.0M FY2025 actual vs. a stated $30-35M FY2026 guidance range). A prior landlord lawsuit (filed August 2024, Alameda Superior Court) was settled promptly in April 2025 for $1.4M. No formal SEC investigation into AEye was identified in the research reviewed. The company regained Nasdaq compliance both times it fell below the $1.00 threshold without being delisted. Commercial-pipeline KPIs (customer count, sequential growth) are disclosed with real specificity each quarter — a level of transparency worth crediting even while absolute revenue remains minimal.
The full current board roster was compiled from multiple partially-dated press sources (a 2021 de-SPAC announcement and a May 2025 appointment) and was not cross-checked against the most recent DEF 14A proxy statement in this research pass. The current CFO's name and the current auditor's name were not identified. Insider and institutional ownership percentages were not conclusively sourced. A vendor-arbitration dollar figure (~$3,300) appeared ambiguous as to units (possibly thousands) and needs primary-source verification. A trade-secrets litigation matter referencing a former employee and a prior employer's information had its current status, and whether AEye itself (versus only an individual defendant) faces financial exposure, not fully clarified in the research reviewed.
Going-concern language ("substantial doubt") appears to have existed in at least one 2025-era filing. Whether this has been formally and permanently lifted in the current Q2 2026 financials could not be confirmed from primary source text in the underlying research — this report treats it as an unresolved, material open item rather than picking a number silently in either direction. The twice-breached Nasdaq minimum-bid-price rule is not adjudicated misconduct, but is a real, recurring compliance pattern and a structural distress signal worth weighting accordingly.
Primary-source confirmation of going-concern status in the next 10-Q; identification of the current CFO and auditor; a full board-roster cross-check against the latest DEF 14A; resolution of the trade-secrets litigation's current status and AEye's exposure (if any); and the pace of ATM/shelf usage and resulting per-share dilution.
Several basic governance data points — current CFO, current auditor, and going-concern status — could not be confirmed from the sourced primary filings in the available research window. That gap is itself informative for a company this small and this thinly covered. Readers should treat the going-concern question in particular as an open item to verify directly against AEye's most recent 10-Q before relying on this report's SELL rating for that specific point — we have deliberately not resolved it silently in either direction.
A standard revenue or earnings multiple is not meaningful given AEye's tiny, negative-margin revenue base (Q2 2026 revenue of $202K against a $161K gross loss), so we use a cash-adequacy framework instead. Current cash & marketable securities are $71.503M (30 Jun 2026) against 45,915,091 weighted-average diluted shares (Q2 2026), i.e. current cash/share ≈ $1.56 — above the current $1.220 share price, a real, sourced fact worth noting on its own. We anchor valuation on the forward (12-month-out) cash trajectory instead: using company-guided FY2026 cash burn of $30-35M (midpoint $32.5M), projected cash in 12 months ≈ $71.5M − $32.5M = $39.0M, over the same 45.915M share base — a stated simplification that ignores further dilution from the new $200M shelf, which we flag separately as a downside risk not embedded in this base number — for a forward cash/share of approximately $0.85. Scenarios below are built as a multiple of this forward cash/share figure.
| Scenario | Multiple of forward cash/share | Target price | Upside/(downside) |
|---|---|---|---|
| Bear — market discounts commercial pipeline entirely | 0.7x | 0.60 | (50.8)% |
| Base — priced at forward liquidity alone | 1.0x | 0.85 | (30.3)% |
| Bull — pipeline converts to a confirmed contract | 1.8x | 1.53 | +25.4% |
Forward cash/share of ~$0.85 = ($71.503M cash − $32.5M guided FY2026 burn midpoint) ÷ 45.915M weighted-average diluted shares; a simplification that does not embed further dilution from the new $200M shelf. Base case rounded to $0.85. The bull case (1.8x) is calibrated to be roughly the same order of magnitude of re-rating the NVIDIA Halos news itself already produced in a single trading day (+52.3%), i.e. real optionality exists if the commercial pipeline converts, but it is not this report's base case.
Upgrade triggers: a confirmed, named automotive OEM series-production design win; a going-concern qualification being formally and confirmably lifted; revenue scaling meaningfully beyond the current ~$200K/quarter base without a proportional increase in cash burn. Downgrade triggers: a third Nasdaq minimum-bid-price deficiency notice; confirmation that going-concern language remains active in the most recent 10-Q; material additional dilution via the $200M shelf/ATM without a corresponding revenue inflection.
| FY2025 | Q2 2025 | Q2 2026 | |
|---|---|---|---|
| Revenue ($000) | 233 | 22 | 202 |
| Gross profit/(loss) ($000) | — | — | (161) |
| GAAP net loss ($mn) | 34.0 | — | 10.0 |
| Selected metrics | Latest |
|---|---|
| Cash, equivalents & marketable securities (30 Jun 2026) | $71.503mn |
| Cash & investments (FY2025 year-end) | $86.5mn |
| FY2026 guided cash burn | $30-35mn |
| Q2 2026 quarterly cash consumption | $7.5mn |
| Revenue-generating customers (Q2 2026) | 25 (+19% QoQ) |
| Weighted-avg diluted shares (Q2 2026) | 45,915,091 |
| Active shelf registration (Form S-3) | $200mn |
Source: AEye, Inc. Q2 2026 results release and Form 10-Q (filed Aug 2026, SEC EDGAR); FY2025 / Q4 2025 results release and Form 10-K; stockanalysis.com (market data, 22 Sep 2026); AEye/BusinessWire and Nasdaq press releases as cited in the underlying research file.
Dart Consultants is a market intelligence and technology service provider, not a SEC-registered Investment Adviser or FINRA-registered Broker-Dealer. This report is educational material only — not investment advice, and not a recommendation to buy or sell any stock. The SELL rating above is an educational device for summarising public information, not a regulated recommendation. The analyst(s) hold no position in, and have no banking, advisory or brokerage relationship with, AEye, Inc., and have received no compensation from the company.
| 12-month target | $0.85 |
| CMP (22 Sep 2026) | $1.220 |
| Implied upside | (30.3)% |
| Rating | SELL |
| Market cap | ~$56.48mn |
| 52-week range | $1.010–$4.000 |
| Cash/share (current) | ~$1.56* |
| Analyst consensus | Strong Buy (mixed)* |
| Auditor | Not identified* |
| Weighted-avg diluted shares (Q2 26) | 45,915,091 |
| Shares outstanding (12 May 26) | 46,314,820 |
| Insider/institutional % | Not conclusively sourced* |
| Q2 25 | Q2 26 | |
|---|---|---|
| Revenue | 22 | 202 |
| Gross profit/(loss) | n/a | (161) |
| Net loss | n/a | 10,000 |
*Q2 2025 gross margin/net loss, aggregate ownership %, analyst-target dates and current auditor were not conclusively sourced in the underlying research — see Governance.